Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining 1.61% today. In the last week its performance is 4.07%, and 32.99% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 344.61, so today’s gain of 1.61% is a significant step towards its target price. The GAP today is therefore 0.64%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 68359.2, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 88.30%.
At the current price of 312, it has a dividend yield of *TBA, and its target price is 344.61. This is with a profit margin of 34.00%, and total debt/equity of 0.57. Biogen Inc. (NASDAQ:BIIB) has a P/E of 18.21, as well as a forward P/E of 14.97.
With a current EPS of 17.13, and a forecasted EPS growth for next year at 3.67%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 31.30%. For the next five years EPS growth is projected to be 8.57%.
Performance for the year is 4.33%. Since its IPO date on 9/17/1991, the total performance to date is 1.84%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 1511600, while its average volume is 1847.99. Whilst the total gain today was 1.61%, it did have a day high of -6.49%.
Volatility for this week has been at 2.02%, and 2.28% for the month. The 52-week low for Biogen Inc., BIIB has been 39.90%, while the 52-week-high has reached -6.49%.
Looking at its return of investments, which is 23.50%, and its return on assets is 18.50%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 47.90%. With a sales growth of 11.70% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.57, and has a current ratio of 3 and 2.6 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 2.12, and the P/S is 6.08, along with a P/B of 5.99. Meanwhile it has a p/cash of 18.